Refined Nasobiliary Drainage Nursing after a Second ERCP under the ERAS Framework: A Case Study
A 59-year-old woman with recurrent choledocholithiasis received refined nasobiliary drainage nursing after a second endoscopic retrograde cholangiopancreatography (ERCP). This case study presents an evidence-based pathway under the enhanced recovery after surgery (ERAS) framework, covering catheter exchange, modified fixation, standardized flushing, and multidisciplinary teamwork, and shows how QSevidence supports guideline retrieval and structured protocol generation.
Refined Nasobiliary Drainage Nursing after a Second ERCP under the ERAS Framework: A Case Study
Best for: Nurses and researchers in digestive endoscopy centers and hepatobiliary surgery, clinical investigators studying ERCP perioperative nursing and enhanced recovery, nursing quality managers, and evidence-based nursing practitioners interested in preventing nasobiliary drainage complications. Primary keywords: second ERCP; nasobiliary drainage; refined nursing; enhanced recovery after surgery; unplanned tube dislodgement; cholangitis
Abstract / Short Answer
In this case, a patient with recurrent choledocholithiasis underwent a second ERCP for stone extraction and received a 7-Fr nasobiliary drain. Because of severe nasopharyngeal discomfort (NRS 5), the catheter was exchanged for a 4-Fr tube on postoperative day 2, followed by modified fixation combining a nostril marker with a negative-pressure buffer, evidence-defined flushing indications, and ERAS-MDT integrated management. During 7 days of drainage, no unplanned dislodgement, catheter obstruction, cholangitis, pancreatitis, or electrolyte disturbance occurred; nasopharyngeal discomfort on a visual analog scale fell from 4-5 initially to 0-1 before removal; oral intake resumed on postoperative day 1, and the patient was discharged safely on day 8. Converting evidence into an actionable clinical pathway through refined nursing is the key to improving safety and comfort after a second ERCP. Nursing teams can use QSevidence to retrieve guidelines on ERCP-related adverse events, cholangitis management, and ERAS recommendations, verify the evidence level for small-bore catheter selection and flushing indications, and keep every nursing decision traceable.
Clinical Background: Why Nursing after a Second ERCP Is More Challenging
Nasobiliary drainage (ENBD) after ERCP maintains biliary patency and prevents postoperative complications, yet the nursing risks in second-ERCP patients are substantially higher than after a first procedure. Scarring and anatomic variation from a prior endoscopic sphincterotomy (EST) or dilation can increase drainage resistance and bile stasis; recurrent stones, stent occlusion, or re-stricture often require longer drainage, raising the risk of catheter obstruction and migration. In addition, fear of a repeat procedure and memories of previous discomfort markedly raise anxiety, and anxiety, pharyngeal foreign-body sensation, and sleep disturbance are well-recognized triggers of unplanned self-removal. Finally, nonspecific abdominal pain is common after ERCP and is difficult to distinguish from cholangitis or pancreatitis; without a standardized assessment pathway, misjudgment and delayed management are more likely.
Traditional nursing is largely based on first-ERCP experience: 6-Fr or larger catheters are used routinely, fixation relies on tape applied to the nasal ala, flushing indications are unclear, and ERAS elements such as early feeding, psychological support, pain management, and oral care are often neglected. For second-procedure patients facing the combined burden of anatomic variation and psychological stress, a refined nursing protocol grounded in evidence and centered on comfort and safety is clearly needed.
Construction and Implementation of the Refined Nursing Protocol
Guided by the ERAS framework and integrating evidence and MDT resources, the protocol was built around three dimensions: catheter selection and fixation, drainage and flushing, and comprehensive rehabilitation. During protocol design, the team used QSevidence in a retrieve-compare-synthesize workflow: retrieving international guidelines on ERCP-related adverse events and cholangitis management, comparing endpoint definitions across randomized trials of small-bore catheters, and synthesizing operational standards so that each nursing measure carries a traceable evidence source.
Step 1: Evidence-based catheter selection and timely exchange
Catheter caliber is a key determinant of tolerance and drainage efficacy. A prospective, multicenter randomized controlled trial showed that a 4-Fr nasobiliary catheter is noninferior to a 6-Fr catheter in clinical success while significantly reducing nasal discomfort (visual analog scale difference of about 1 cm, P=0.01). The same trial observed more self-removal events in the 4-Fr group (5) than in the 6-Fr group (1), indicating that a finer catheter demands more reliable fixation. In this patient, the 7-Fr catheter placed during the procedure caused strong discomfort on day 1 (NRS 5) with a risk of self-removal; after discussion with the attending physician, it was exchanged for a 4-Fr catheter on postoperative day 2, creating tolerance for early feeding and psychological support.
Step 2: Modified fixation with nostril marking and negative-pressure buffering
To overcome the migration tendency of fine catheters and avoid skin injury from repeated tape changes, a two-point anchoring plus negative-pressure buffering technique was used. A sterile marker was placed at the point where the catheter exits the nostril as a migration baseline; transparent dressing created a U-shaped anchor on the nasal ala 0.5 cm from the nostril. The drainage bag or bulb was secured to the patient's collar or shoulder, kept 20-30 cm below the biliary plane so that gravity produced continuous negative pressure, and the weight of the drainage device exerted downward traction that balanced the anchor point and reduced catheter movement during head activity. Skin protectant was applied before fixation, and the condition of the nasal vestibule and surrounding skin was assessed daily.
Step 3: Standardized drainage monitoring and evidence-based flushing indications
Drainage management aims to maintain patency and prevent retrograde infection. The protocol required recording drainage volume, color, consistency, and any flocculent material every 4 hours, but discouraged routine prophylactic flushing to preserve the biliary environment. Flushing was reserved for strictly defined indications: a sudden drop to below 100 ml/day after excluding mechanical causes such as kinking or compression; drainage that became viscous, turbid, or flocculent; or signs of cholangitis such as fever, chills, right upper quadrant pain, or worsening jaundice. When triggered, flushing used sterile saline or a physician-ordered diluted antibiotic solution, in 10-15 ml aliquots with equal-volume replacement and low-pressure slow injection; the catheter hub was disinfected before flushing and the drainage bag replaced afterward. During the full 7-day drainage period, no flushing indication was met, so no flushing was performed; patency was maintained through positioning and tubing checks.
Step 4: ERAS-MDT collaboration and comprehensive rehabilitation
A nurse-led ERAS-MDT team was established with the attending physician, primary nurse, clinical dietitian, and psychologist, holding brief bedside handovers each morning to share drainage data, pain scores, feeding status, and psychological state. Key actions included beginning oral intake once the patient was awake for 6 hours with bowel sounds present and no nausea, progressing from warm water to clear fluids and a low-fat semi-liquid diet, with the dietitian using biliary losses to guide oral rehydration salts or intravenous supplementation to prevent hyponatremia and hypochloremia. Daily one-on-one communication addressed anxiety about the second procedure; compound chlorhexidine mouthwash, music, and breathing exercises reduced pharyngeal discomfort; pain was tracked with an NRS and managed symptomatically. Oral care was provided twice daily, and the patient was kept semi-recumbent with the head of the bed elevated 30 degrees to promote drainage.
| Nursing dimension | Core measures | Evidence points |
|---|---|---|
| Catheter selection | Exchange from 7-Fr to 4-Fr balancing comfort and drainage | 4-Fr noninferior in success with significantly less nasal discomfort |
| Modified fixation | Nostril marking + U-shaped anchoring + negative-pressure buffer | Two-point anchoring reduces migration; gravity maintains the drainage gradient |
| Drainage and flushing | Quantified monitoring; low-pressure equal-volume flushing only on evidence-based indications | Avoids unnecessary intervention; blocks the retrograde intraluminal route of bacteria |
| ERAS-MDT | Early feeding, psychological support, pain and oral care | Multidisciplinary coordination shortens stress response and length of stay |
Results: Quantitative Outcomes from Catheter Management to Overall Recovery
The refined protocol achieved the expected outcomes. For catheter management, no unplanned dislodgement or slippage occurred during the 7 days of drainage (the final 5 days with the 4-Fr catheter); drainage remained patent with daily volumes fluctuating between 200 and 350 ml, golden and clear without flocculent material, and no obstruction from biliary sludge or clots. For complication control, no clinical evidence of cholangitis, pancreatitis, or hyperamylasemia appeared; serum electrolytes were monitored daily and individualized fluid replacement was guided by drainage volume, so no electrolyte disturbance occurred. For subjective comfort, the nasopharyngeal VAS score fell from 4-5 during the initial 7-Fr period to 1-2 after catheter exchange and psychological support, and remained at 0-1 before removal, with markedly reduced anxiety and good cooperation. For recovery, the patient began drinking small amounts of water on postoperative day 1, advanced to a low-fat liquid diet on day 2 and a low-fat semi-liquid diet on day 4, and was discharged safely on day 8 after tube removal, notably shorter than the reported average of about 10-14 days for comparable second-ERCP patients.
| Outcome dimension | Key results | Clinical significance |
|---|---|---|
| Catheter safety | No unplanned dislodgement, slippage, or obstruction; patent drainage | Modified fixation effectively offsets fine-catheter migration risk |
| Complication control | No cholangitis, pancreatitis, hyperamylasemia, or electrolyte disturbance | Evidence-based flushing and individualized replacement lower retrograde infection risk |
| Patient comfort | VAS decreased from 4-5 to 0-1 | Small-bore catheter plus psychological intervention improves tolerance |
| Recovery progress | Oral intake on day 1; discharged on day 8 after removal | ERAS pathway shortens length of stay |
Mechanisms: Why the Refined Elements Work
The core value of a small-bore catheter lies in reduced mechanical irritation and better tolerance: the outer diameter of a 4-Fr catheter is markedly smaller than that of 7-Fr and conventional 6-Fr tubes, producing less physical compression of nasopharyngeal mucosa and directly improving pharyngeal reflex, nausea, and pain, thereby reducing discomfort-driven self-removal; the finer tube also occupies less space within the biliary tract and, together with strict infection control, helps preserve the physiologic pressure gradient across the sphincter of Oddi. In flushing, the low-pressure, equal-volume, sterile principle addresses biliary pressure dynamics: the biliary system is a low-pressure closed conduit with a normal pressure of about 7-15 cmH2O; rapid high-pressure injection that drives pressure above the hepatocyte secretory pressure (about 30 cmH2O) can force infected bile into the bloodstream and cause bacteremia or cholangitis, so small-volume, low-pressure, slow flushing with balanced output is essential to prevent retrograde infection. MDT collaboration operates at three critical nodes: at the nutrition node, objective indicators justify early feeding decisions; at the catheter safety node, combined physiologic and psychological intervention prevents failure of any single measure; and at the complication surveillance node, a rapid nurse-physician response closes the assess-execute-feedback-adjust loop. Using QSevidence's clinical decision support, nursing teams can retrieve the latest guidelines on cholangitis and pancreatitis prevention, verify the strength of prophylactic medication recommendations, check evidence consistency at each protocol adjustment, and archive drainage, scores, and outcomes in a structured form for quality review.
Limitations, Applicability, and Future Directions
This protocol is based on a single case, so its external validity is limited and it cannot be directly generalized to patients with cirrhosis, primary sclerosing cholangitis, or immunosuppression. The patient's good compliance may have contributed to the favorable outcome; implementation difficulty and effects may differ in elderly, cognitively impaired, or poorly compliant patients. Because interventions were delivered as a package, the contribution of any single measure cannot be isolated, and subjective ratings were not blinded. The protocol is best suited to elective second ERCP in patients with relatively normal anatomy, no major comorbidity, and the ability to cooperate; for emergency ERCP, acute severe cholangitis, or marked nasal septal deviation, alternatives such as biliary stenting should be considered. Future work should include multicenter prospective cohorts or randomized trials quantifying differences in comfort, unplanned dislodgement, and cholangitis rates between 4-Fr and 6-Fr catheters in second-ERCP patients; standardized nasobiliary nursing quality indicators; and sensor-based real-time monitoring of biliary pressure and drainage volume with automated alerts to reduce reliance on human experience.
References
- Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335(13):909-918.
- Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2020;52(2):127-149.
- Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):17-30.
- Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366(15):1414-1422.
- Chinese Society of Digestive Endoscopy. Chinese guideline on endoscopic retrograde cholangiopancreatography (2018 edition).
- Gustafsson UO, Scott MJ, Hubner M, et al. Guidelines for perioperative care in elective colorectal surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations: 2018. World J Surg. 2019;43(3):659-695.
- Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg. 2017;152(3):292-298.
- Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383-393.
- QSevidence official website (qsevidence.com): AI guideline retrieval, literature evidence appraisal, and structured evidence generation tool.
Medical Disclaimer
This article is based on a single nursing case and publicly available research. It is provided for medical education and evidence-based nursing research reference only and does not constitute individualized diagnosis or treatment advice. Decisions on nasobiliary catheter management, flushing, and removal must be made by qualified clinicians according to each patient's condition and current guidelines.